ASSESSMENT OF QUALITY AND ADEQUACY OF PANRETINAL PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC RETINOPATHY USING ULTRA-WIDEFIELD IMAGING.
Journal
Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
medline:
26
10
2023
pubmed:
25
7
2023
entrez:
25
7
2023
Statut:
ppublish
Résumé
To assess the characteristics of completed panretinal photocoagulation (PRP), using ultra-widefield imaging in proliferative diabetic retinopathy. Quantitative assessment of ultra-widefield imaging images of 133 patients with proliferative diabetic retinopathy with completed PRP was made using ImageJ software. The parameters assessed included distance of laser spots from the optic disk, foveal center, superior and inferior arcades, and extent of the maximum width of laser. Areas assessed were total area of the image, area of the inner limit within which laser spots are restricted, minimum areas of unlasered patches, total area lasered, and ideal area to be covered by PRP. Two hundred one images were assessed for the final analysis. The mean distance of laser spots was 4.2 ± 2.4 mm from the optic disk (nasal) and 6.6 ± 2.5 mm from the foveal center (temporal). The mean distance of laser spots from the superior arcade vessel was 3.2 ± 1.9 mm and 6.2 ± 4.4 mm from the inferior arcade. The mean area of the retina that should have been ideally lasered was found to be 900 ± 267 mm 2 , and the actual area lasered was found to be 681 ± 254.4 mm 2 . Approximately one-quarter area of the retina continues to remain ischemic because of the lack of inadequate coverage of PRP. Further longitudinal studies are recommended, using ultra-widefield imaging to objectively assess the adequacy of PRP and its role in modulating the course of progression of the retinopathy.
Identifiants
pubmed: 37490757
doi: 10.1097/IAE.0000000000003902
pii: 00006982-202311000-00011
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1922-1927Références
GBD 2019 Blindness and Vision Impairment Collaborators. Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 2021;9:e144–e160.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology 1991;98, 766–785.
Neubauer AS, Kernt M, Haritoglou C, et al. Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefe's Archive Clin Exp Ophthalmol 2008;246:229–235.
Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8. The diabetic retinopathy study research group. Ophthalmology 1981;88:583–600.
Liu TYA, Arevalo JF. Wide-field imaging in proliferative diabetic retinopathy. Int J Retina Vitreous 2019;5:20.
Ghasemi Falavarjani K, Wang K, Khadamy J, Sadda SR. Ultra- wide-field imaging in diabetic retinopathy; an overview. J Curr Ophthalmol 2016;28:57–60.
Byberg S, Vistisen D, Diaz L, et al. Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes. Acta Ophthalmol 2019;97:815–820.
Sodhi SK, Golding J, Trimboli C, Choudhry N. Feasibility of peripheral OCT imaging using a novel integrated SLO ultra-widefield imaging swept-source OCT device. Int Ophthalmol 2021;41:2805–2815.
Gisung S, Suchan L, Hee Young J, et al. Ultra-wide field angiography improves the detection of proliferative diabetic retinopathy progression. J Diabetes Metab 2014;05:1–6.
Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741–756.
Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 2018;19:1816.
JAEB Center for Health Research. Protocol AA. Available at: https://public.jaeb.org/drcrnet/stdy/239 . Accessed August 13, 2019.
Silva PS, Cavallerano JD, Haddad NM, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology 2015;122:949–956.
Elmasry MA, Silva PS, Cavallerano J, et al. Incorporating predominantly peripheral diabetic retinopathy (DR) lesion identification in a teleophthalmology program predicts DR progression over 4 years in eyes with early DR. Invest Ophthalmol Vis Sci 2018;59:740.
Wessel MM, Nair N, Aaker GD, et al. Peripheral retinal ischaemia, as evaluated by ultra- widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol 2012;96:694–698.
Patel SN, Shi A, Wibbelsman TD, Klufas MA. Ultra-widefield retinal imaging: an update on recent advances. Ther Adv Ophthalmol 2020;12:251584141989949.
Torp TL, Kawasaki R, Wong TY, et al. Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation. Br J Ophthalmol 2019;103:816–820.
Yu G, Aaberg MT, Patel TP, et al. Quantification of retinal nonperfusion and neovascularization with ultrawidefield fluorescein angiography in patients with diabetes and associated characteristics of advanced disease. JAMA Ophthalmol 2020;138:680–688.
Bailey CC, Sparrow JM, Grey RH, Cheng H. The national diabetic retinopathy laser treatment audit. III. Clinical outcomes. Eye 1999;13:151–159.